James Lumsdaine
Interim Chief Executive Officer
In February of 2022 Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real-world data, and Canexia Health, an oncology innovator that streamlines complex cancer genomic information for use in treatment selection and patient monitoring, came together to form Imagia Canexia Health. Together, Imagia Canexia Health accelerates access to precision oncology leading to optimized treatment selection and better patient outcomes. Our expertise in genomics-based cancer assays, bioinformatics, and machine learning runs deep thanks to the strong foundation laid by our combined scientific, medical, and business leader
